1300018I emory university; vteu; to 75N93020F00001-17-0111.B1C1D1.0126--task area b-d wolbachia-infected aedes aegypti mosquitos in reducing arboviral infection brazil
Active Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,999,514
Award facts
- Contract value 100% obligated
- $7,999,514.00 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- 2135 N Keene Rd, Clearwater, FL 33763, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$129 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $7,999,643 |
About this award
This federal contract award, issued by the National Institute of Allergy and Infectious Diseases (NIAID), provides $7,999,514.00 to Emory University to conduct research on the use of Wolbachia-infected Aedes aegypti mosquitoes in reducing arboviral infection in Brazil. The contract is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) master contract, which supports medical research and development initiatives. The award does not have a set-aside designation, indicating Emory's competitive technical capabilities in this research area. Key subcontractors include The Johns Hopkins University, Yale University, the University of Florida, and the Fundacao De Desenvolvimento DA Pesquisa (FUNDEP) in Brazil. This contract supports NIAID's mission to conduct research and develop medical countermeasures for infectious diseases, leveraging Emory's expertise in biomedical research, tropical disease studies, and international collaborations.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 4, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $7,999,514 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award